TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 28 filers reported holding TENAX THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $36,000 | +16.1% | 75,437 | -13.9% | 0.00% | – |
| Q3 2017 | $31,000 | -51.6% | 87,632 | 0.0% | 0.00% | – |
| Q2 2017 | $64,000 | +25.5% | 87,632 | -4.5% | 0.00% | – |
| Q1 2017 | $51,000 | -71.2% | 91,755 | +0.6% | 0.00% | – |
| Q4 2016 | $177,000 | -14.9% | 91,197 | +0.4% | 0.00% | – |
| Q3 2016 | $208,000 | -10.3% | 90,825 | +0.1% | 0.00% | – |
| Q2 2016 | $232,000 | +24.7% | 90,732 | 0.0% | 0.00% | – |
| Q1 2016 | $186,000 | -37.4% | 90,732 | -0.1% | 0.00% | – |
| Q4 2015 | $297,000 | +17.9% | 90,825 | +8.9% | 0.00% | – |
| Q3 2015 | $252,000 | -14.9% | 83,418 | +3.7% | 0.00% | – |
| Q2 2015 | $296,000 | +13.0% | 80,411 | 0.0% | 0.00% | – |
| Q1 2015 | $262,000 | -14.9% | 80,411 | 0.0% | 0.00% | – |
| Q4 2014 | $308,000 | -2.5% | 80,411 | 0.0% | 0.00% | – |
| Q3 2014 | $316,000 | – | 80,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $3,636,000 | 1.53% |
| ARMISTICE CAPITAL, LLC | 990,000 | $3,247,000 | 1.16% |
| RA Capital Management | 2,389,700 | $7,838,000 | 0.78% |
| Opaleye Management Inc. | 540,000 | $1,771,000 | 0.74% |
| SABBY MANAGEMENT, LLC | 2,693,537 | $8,835,000 | 0.49% |
| Broadfin Capital, LLC | 1,968,631 | $6,457,000 | 0.40% |
| DAFNA Capital Management LLC | 79,509 | $261,000 | 0.23% |
| BOURGEON CAPITAL MANAGEMENT LLC | 55,500 | $182,000 | 0.12% |
| BAILARD, INC. | 60,000 | $197,000 | 0.09% |
| Verition Fund Management LLC | 32,140 | $105,000 | 0.02% |